skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

14 studies were found about boceprevir

A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)

Condition: HIV Infections; Hepatitis C; HCV Infection

NCT ID: NCT00959699

Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir

Condition: HIV Infections; HCV Infections

NCT ID: NCT01288417

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

Condition: HCV Coinfection; HIV-1 Infection

NCT ID: NCT01335529

Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers

Condition: Hepatitis C; HIV

NCT ID: NCT01427504

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

Condition: Hepatitis C, Chronic; HIV

NCT ID: NCT01925183

A Study to Evaluate Safety and Efficacy of Boceprevir-response Guided Therapy in Controlled HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Condition: HCV and HIV Seropositive Coinfection

NCT ID: NCT01718301

Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT01482767

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Condition: Hepatitis; HIV/AIDS

NCT ID: NCT01443923

Dutch Acute HCV in HIV Study (DAHHS)

Condition: Hepatitis C; Human Immunodeficiency Virus

NCT ID: NCT01912495

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Condition: Hepatitis C, Chronic; Human Immunodeficiency Virus

NCT ID: NCT02057003

A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01563328

THISTLE - The HIV-HCV Silibinin Trial

Condition: HIV; Hepatitis C

NCT ID: NCT01816490

The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers

Condition: Healthy

NCT ID: NCT01627717

Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects

Condition: Healthy

NCT ID: NCT01597895